Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
53.5M
-
Shares change
-
-425K
-
Total reported value, excl. options
-
$2.37B
-
Value change
-
-$1.95M
-
Put/Call ratio
-
1.16
-
Number of buys
-
91
-
Number of sells
-
-75
-
Price
-
$44.20
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q3 2024
203 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.5M shares
of 64.3M outstanding shares and own 83.2% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (4.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.94M shares), BlackRock, Inc. (3.45M shares), Sofinnova Investments, Inc. (2.79M shares), FMR LLC (2.79M shares), VANGUARD GROUP INC (2.58M shares), COMMODORE CAPITAL LP (2.48M shares), Eversept Partners, LP (2.05M shares), Holocene Advisors, LP (1.95M shares), and STATE STREET CORP (1.82M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.